Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Advanta VXT and Flixene PMCF Registry

NCT: NCT07161583 · RECRUITING

NCT IDNCT07161583
StatusRECRUITING
Start Date2025-09-25
Completion2027-12
SponsorAtrium Medical Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular grafts.

Frequently Asked Questions

What is Advanta VXT and Flixene PMCF Registry?

Advanta VXT and Flixene PMCF Registry is a clinical trial registered under NCT07161583. Current status: RECRUITING.

What is the status of NCT07161583?

The current status of NCT07161583 (Advanta VXT and Flixene PMCF Registry) is: RECRUITING.

When did Advanta VXT and Flixene PMCF Registry start?

Advanta VXT and Flixene PMCF Registry started on 2025-09-25.

Related Devices

K231972Advanta VXT Vascular Graft, Flixene Vascular GraftAtrium Medical Corporation K201305Auto transfusion (ATS) Chest Drains: Ocean Water Seal Chest Drain, Oasis Dry Suction Water Seal Chest Drain, Express Dry Seal Chest DrainAtrium Medical Corporation PMA P120003Iliac covered stent, arterialAtrium Medical Corp.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑